| Preface |
|
ix | |
| Contributors |
|
xi | |
| Part 1 Introduction |
|
1 | (10) |
|
Plants in medicine: the origins of pharmacognosy |
|
|
3 | (2) |
|
The scope and practice of pharmacognosy |
|
|
5 | (3) |
|
Plant nomenclature and taxonomy |
|
|
8 | (3) |
| Part 2 The plant and animal kingdoms as sources of drugs |
|
11 | (44) |
|
Biological and geographical sources of drugs |
|
|
13 | (2) |
|
A taxonomic approach to the study of medicinal plants and animal-derived drugs |
|
|
15 | (26) |
|
Pharmacological activities of natural products |
|
|
41 | (8) |
|
Synergy in relation to the pharmacological action of phytomedicinals |
|
|
49 | (6) |
|
|
|
|
|
| Part 3 Principles related to the commercial production, quality and standardization of natural products |
|
55 | (52) |
|
|
|
57 | (4) |
|
|
|
|
|
|
Production of crude drugs |
|
|
61 | (6) |
|
|
|
67 | (5) |
|
Plant cell and tissue culture; biological conversions; clonal propagation |
|
|
72 | (8) |
|
Phytochemical variation within a species |
|
|
80 | (11) |
|
Deterioration of stored drugs |
|
|
91 | (4) |
|
|
|
95 | (12) |
| Part 4 Some current trends |
|
107 | (28) |
|
Plant products and High Throughput Screening |
|
|
109 | (6) |
|
|
|
|
|
|
|
|
|
|
|
Biologically active compounds from marine organisms |
|
|
115 | (10) |
|
|
|
|
|
|
Traditional plant medicines as a source of new drugs |
|
|
125 | (10) |
|
|
|
|
|
| Part 5 Phytochemistry |
|
135 | (36) |
|
General methods associated with the phytochemical investigation of herbal products |
|
|
137 | (13) |
|
Basic metabolic pathways and the origin of secondary metabolites |
|
|
150 | (21) |
| Part 6 Pharmacopoeial and related drugs of biological origin |
|
171 | (274) |
|
|
|
173 | (1) |
|
Hydrocarbons and derivatives |
|
|
174 | (17) |
|
|
|
191 | (23) |
|
Phenols and phenolic glycosides |
|
|
214 | (39) |
|
|
|
253 | (36) |
|
Saponins, cardioactive drugs and other steroids |
|
|
289 | (26) |
|
Miscellaneous isoprenoids |
|
|
315 | (12) |
|
Cyanogenetic glycosides, glucosinolate compounds and miscellaneous glycosides |
|
|
327 | (6) |
|
|
|
333 | (61) |
|
Tumour inhibitors from plants |
|
|
394 | (13) |
|
|
|
|
|
|
Antiprotozoal natural products |
|
|
407 | (7) |
|
|
|
|
|
|
An overview of drugs with antihepatotoxic and oral hypoglycaemic activities |
|
|
414 | (7) |
|
|
|
421 | (8) |
|
Antibacterial and antiviral drugs |
|
|
429 | (6) |
|
Colouring and flavouring agents |
|
|
435 | (5) |
|
|
|
440 | (5) |
| Part 7 Plants in complementary and traditional systems of medicine |
|
445 | (52) |
|
|
|
447 | (2) |
|
Herbal medicine in Britain and Europe: regulation and practice |
|
|
449 | (11) |
|
|
|
|
|
|
Homoeopathic medicine and aromatherapy |
|
|
460 | (7) |
|
|
|
|
|
|
|
|
|
|
|
Aspects of Asian medicine and its practice in the West |
|
|
467 | (15) |
|
|
|
|
|
|
Chinese herbs in the West |
|
|
482 | (6) |
|
|
|
|
|
|
Plants in African traditional medicine---an overview |
|
|
488 | (9) |
|
|
|
|
|
| Part 8 Nonmedicinal toxic plants and pesticides |
|
497 | (16) |
|
Hallucinogenic, allergenic, teratogenic and other toxic plants |
|
|
499 | (10) |
|
Pesticides of natural origin |
|
|
509 | (4) |
| Part 9 Morphological and microscopical examination of drugs |
|
513 | (36) |
|
|
|
515 | (1) |
|
Plant description, morphology and anatomy |
|
|
516 | (10) |
|
Cell differentiation and ergastic cell contents |
|
|
526 | (12) |
|
|
|
538 | (11) |
| Index |
|
549 | |
Shopping Cart
